Co-founder and CEO
Mr. Ashton has extensive experience in driving successful marketing, sales, IPO and M&A strategies for advanced-technology companies. His experience includes serving as a senior vice president, sales and marketing at Megahertz—a publicly-held company with annual sales in excess of $150 Million; as a senior officer at Inari, a pre-IPO technology start-up; and as CEO of Printelligent Corporation. Mr. Ashton has a proven track record in successfully managing diverse teams of personnel—scientists, marketing, sales and administrative resources—in high-growth technology companies.
Chief Financial Officer
Mr. Rona is a seasoned executive in the healthcare and biotech industry, with over 20 years of experience in originating, structuring and executing corporate transactions and financings. Prior to joining Great Basin, he was chief business officer of GlobeImmune, a private biopharmaceutical company developing treatments for cancer and infectious diseases. He was vice president of Corporate Development at Corgentech, Inc., following its merger with AlgoRx Pharmaceuticals. Mr. Rona helped execute the transaction in his role as CFO of AlgoRx prior to the merger. Mr. Rona also served in the investment banking department of UBS Warburg, and as director of finance and corporate development at Agenus, where he was instrumental in its IPO. He started his career at Coopers & Lybrand. Mr. Rona has a B.S. in Accounting from Case Western Reserve University.
Senior Vice President, R&D and Chief Technology Officer
Mr. Jenison joined Great Basin Corporation from BioStar, an Inverness Medical Innovations Inc. company (formerly Thermo Electron), where he served as associate director of Research and Development. At BioStar, Jenison directed a team in developing rapid nucleic acid diagnostic assays, created and then executed the go-to-market strategy for the platform, and was nominated for the Thermo Electron Life and Laboratory sector’s Innovation Award for development of the CF genotyping test. Jenison has been awarded four patents based on his work with nucleic acid ligands and arrayed elements; furthermore his work has been published in numerous scientific journals. Jenison holds a bachelors degree in Chemistry from Revelle College, University of California at San Diego.
Senior Vice President, Sales and Marketing, HR
Ms. Nielsen is a seasoned executive with extensive success in building and executing customer acquisition programs for high–growth technology start–ups. Nielsen joins Great Basin from Pearson PLC where she served as senior director of marketing for the Data Solutions business unit (formerly Edustructures). During her tenure at Edustructures, she created and implemented aggressive marketing and customer acquisition programs that positioned the company for purchase by Pearson. Prior to Pearson, Nielsen served as the senior director of marketing for Omniture where she executed programs that contributed to the company’s record–setting (100 percent year–over–year) revenue growth in preparation for the company’s 2006 IPO. Nielsen spearheads the company’s global sales and marketing efforts, managing both the direct sales team as well as the distributor network and leads the customer/technical support operations. Nielsen also oversees product management and user experience, as well as corporate communications and public relations efforts.
Vice President, Product Development
Dr. Lindsey joins from Nanosphere, Inc. where he was the associate director of Assay Development, Infectious Disease. At Great Basin, Dr. Lindsey is responsible for the development of IVD (In Vitro Diagnostics) assays from feasibility to FDA 510(k) clearance and market, and for directing reagent manufacturing and quality control. He received his Ph.D. in Genetics and Molecular Biology from Emory University, Atlanta, Ga., and an MBA from Georgia State University.
Vice President, Engineering
Dr. Carlos González joined Great Basin Scientific from Abbott Point of Care where he served as R&D Director of Instrument Development. Prior to Abbott POC he held positions in new technology development with Siemens Diagnostics, Abbott Pharmaceutical (now Abbvie), and Lawrence Livermore National Laboratories where he helped demonstrate real-time PCR on a chip with nL volumes. At Great Basin, Dr. Gonzalez is responsible for analyzer and cartridge systems development. He received his Ph.D. in Electrical Engineering from University of California at Davis.